Search

everythinglearnresearchcommunity

for

Search:↓

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Both estrogens and androgens are important for health in both males and females.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Hair loss in postmenopausal woman caused by ovarian issue.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Treatments for hair loss include estrogen therapy and special shampoos.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Testosterone's effects on COVID-19 are unclear and need more research.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Most women with excessive hair growth in South India have hirsutism without a known cause, with common facial hair growth and some showing hormonal imbalances and polycystic ovaries.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.